دورية أكاديمية
Retinal Vein Occlusion in Benin City, Nigeria.
| العنوان: | Retinal Vein Occlusion in Benin City, Nigeria. |
|---|---|
| المؤلفون: | Uhumwangho OM; Department of Ophthalmology, University of Benin Teaching Hospital, P.M.B 1111, Benin City, Nigeria., Oronsaye D; Department of Ophthalmology, University of Benin Teaching Hospital, P.M.B 1111, Benin City, Nigeria. |
| المصدر: | Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society [Niger J Surg] 2016 Jan-Jun; Vol. 22 (1), pp. 17-20. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Medknow Country of Publication: India NLM ID: 101189891 Publication Model: Print Cited Medium: Print ISSN: 1117-6806 (Print) Linking ISSN: 11176806 NLM ISO Abbreviation: Niger J Surg Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: <2011-2021> : Mumbai : Medknow Original Publication: Lagos, Nigeria : Nigerian Surgical Research Society |
| مستخلص: | Background: Retinal vein occlusion (RVO) is the most common occlusive retinal vascular disorder and results in varying degrees of visual loss. Aim: To determine the pattern of presentation, risk factors, and treatment outcomes in a group of patients with RVO seen in a tertiary hospital in Nigeria. Materials and Methods: Medical records of patients who presented to the University of Benin Teaching Hospital, Benin City, Nigeria in whom a diagnosis of RVO was made over a 5 years period were reviewed. Data obtained were analyzed with the GraphPad Instat Software, Inc. version V2.05a program, San Diego, Califonia and a P < 0.05 considered significant. Results: There were 20 patients made of 14 (70.0%) males and 6 (30.0%) females with a mean age of 62.7 ± 10.4 years. There were 15 (68.2%) eyes with central RVO, 3 (13.6%) eyes with branch RVO, and 4 (18.2%) eyes with hemi RVO. Bilateral involvement occurred in 2 (10.0%) patients. Risk factors included hypertension 14 (70.0%), diabetes mellitus 9 (45.0%), and glaucoma 5 (22.7%). Multiple risk factors were present in 14 (70.0%) patients. Complications included macula edema 15 (68.2%), retinal neovascularization 5 (22.7%), neovascular glaucoma 3 (13.6%), and vitreous hemorrhage 2 (9.1%). Eyes which had definitive treatment with intravitreal antivascular endothelial growth factors and laser photocoagulation for macula edema and retinal neovascularization, respectively, had better visual acuity compared to eyes which did not receive these treatment, P = 0.002. Conclusion: The incidence and visual loss that occurs from RVO can be reduced by modifying known risk factors and early institution of appropriate therapy for complications that occur. |
| References: | Ophthalmology. 2010 Jun;117(6):1124-1133.e1. (PMID: 20381871) Br J Ophthalmol. 2008 Oct;92(10):1316-9. (PMID: 18684751) Am J Ophthalmol. 1978 Dec;86(6):798-801. (PMID: 736077) Ophthalmology. 2011 Aug;118(8):1594-602. (PMID: 21684606) Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4297-302. (PMID: 18539932) Ophthalmology. 1992 Apr;99(4):509-14. (PMID: 1584567) Ophthalmology. 2011 Oct;118(10):2041-9. (PMID: 21715011) Arch Ophthalmol. 1996 Oct;114(10):1243-7. (PMID: 8859084) Clin Ophthalmol. 2011;5:745-9. (PMID: 21750607) Ophthalmologica. 1988;197(2):69-74. (PMID: 3186211) N Engl J Med. 2010 Nov 25;363(22):2135-44. (PMID: 21105795) Trans Am Ophthalmol Soc. 2000;98:133-41; discussion 141-3. (PMID: 11190017) Arch Ophthalmol. 1997 Apr;115(4):486-91. (PMID: 9109757) Br J Ophthalmol. 2009 Apr;93(4):452-6. (PMID: 19074916) J Korean Med Sci. 2013 Jan;28(1):136-44. (PMID: 23341724) Arch Ophthalmol. 2008 Apr;126(4):513-8. (PMID: 18413521) Arch Ophthalmol. 2006 May;124(5):726-32. (PMID: 16682596) Indian J Ophthalmol. 1994 Sep;42(3):109-32. (PMID: 7829175) Niger J Clin Pract. 2014 Jul-Aug;17(4):462-6. (PMID: 24909470) Ophthalmology. 2014 Jul;121(7):1414-1420.e1. (PMID: 24679444) Am J Ophthalmol. 2001 Jan;131(1):61-77. (PMID: 11162981) Am J Ophthalmol. 1994 Apr 15;117(4):429-41. (PMID: 8154523) Ophthalmology. 2012 Apr;119(4):802-9. (PMID: 22301066) Clin Ophthalmol. 2011;5:705-13. (PMID: 21629578) Ophthalmology. 1990 Nov;97(11):1543-8. (PMID: 2255527) Ophthalmology. 2010 Feb;117(2):313-9.e1. (PMID: 20022117) Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3205-9. (PMID: 20071683) Ophthalmology. 2005 Apr;112(4):540-7. (PMID: 15808241) Ophthalmology. 2010 Jun;117(6):1102-1112.e1. (PMID: 20398941) |
| فهرسة مساهمة: | Keywords: Intravitreal antivascular endothelial growth factors; laser photocoagulation; retinal vein occlusion |
| تواريخ الأحداث: | Date Created: 20160326 Date Completed: 20160325 Latest Revision: 20201001 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC4785686 |
| DOI: | 10.4103/1117-6806.169871 |
| PMID: | 27013853 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1117-6806 |
|---|---|
| DOI: | 10.4103/1117-6806.169871 |